Multinational pharmaceutical companies have been accused of not doing enough to find a cure for the deadly Ebola virus.

The disease has killed more than 1,200 in West Africa, but analysts say drug firms lack motivation to research for a treatment because there is little financial incentive.

Al Jazeera's Rob Reynolds reports from Washington.

Source: Al Jazeera